Postnatal developmental changes of vitreous and lens volumes in Sprague-Dawley rats

Neuroembryology and Aging

Volumn 4, Issue 4, 2006, Pages 183-188

  Sha, O ^a   Kwong, W H ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

Eye; Lens volume; Postnatal development; Rat; Vitreous volume

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EYE DEVELOPMENT; EYE FIXATION; INTRAOCULAR PRESSURE; LENS EPITHELIUM; MORPHOLOGY; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; TISSUE SECTION; VITREOUS BODY;

RATTUS;

EID: 41149128319     PISSN: 16613406     EISSN: 16613414     Source Type: Journal    
DOI: 10.1159/000118928     Document Type: Article

References (52)

1. Remington LA: Clinical Anatomy of the Visual System. Boston, Butterworth-Heinemann, 1998.
2. Forrester JV, Dick AD, McMenamin PG, Lee WR: The Eye: Basic Sciences in Practice. Edinburgh, WB Saunders, 2002.
3. Eisner G: Clinical Anatomy of the Vitreous. Philadelphia, Lippincott, 1994.
4. Lens A, Langley T, Nemeth SC, Shea C: Ocular Anatomy and Physiology. Thorofare, SLACK, 1999.
5. Kumar CM, Dodds C, Fanning GL: Ophthalmic Anaesthesia. Lisse, Swets & Zeitlinger Publishers, 2002.
6. Rittenhouse KD, Pollack GM: Microdialysis and drug delivery to the eye. Adv Drug Deliv Rev 2000;45:229-241.
7. Kamei M, Estafanous M, Lewis H: Tissue plasminogen activator in the treatment of vitreoretinal diseases. Semin Ophthalmol 2000;15:44-50.
8. Dureau P, Bonnel S, Menasche M, Dufier JL, Abitbol M: Quantitative analysis of intravitreal injections in the rat. Curr Eye Res 2001;22:74-77.
9. Aiello LP, Brucker AJ, Chang S, Cunningham ET Jr, D'Amico DJ, Flynn HW Jr, Grillone LR, Hutcherson S, Liebmann JM, O'Brien TP, Scott IU, Spaide RF, Ta C, Trese MT: Evolving guidelines for intravitreous injections. Retina 2004;24(suppl 5):S3-S19.
10. Yasukawa T, Ogura Y, Tabata Y, Kimura H, Wiedemann P, Honda Y: Drug delivery systems for vitreoretinal diseases. Prog Retin Eye Res 2004;23:253-281.
11. Carstocea B, Macovei L: Intravitreal administration of drugs. Oftalmologia 2005;49:5-9.
12. Dwinger MC, Pieper-Bodeewes I, Eter N, Holz FG: Variations in intraocular pressure (IOP) and necessity for paracentesis following intravitreal triamcinolone injection. Klin Monatsbl Augenheilkd 2005;222:638-642.
13. Myles ME, Neumann DM, Hill JM: Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis. Adv Drug Deliv Rev 2005;57:2063-2079.
14. Kourlas H, Schiller DS: Pegaptanib sodium for the treatment of neovascular age-related macular degeneration: a review. Clin Ther 2006;28:36-44.
15. Hill CE, Vidovic M: The role of competition in the refinement of the projections of sympathetic neurons to the rat eye during development. Int J Dev Neurosci 1989;7:539-551.
16. Ehrlich D, Sattayasai J, Zappia J, Barrington M: Effects of selective neurotoxins on eye growth in the young chick. Ciba Found Symp 1990;155:63-84.
17. Sha O, Kwong WH, Cho YP, Yew DT: Neuronal toxicity of type I ribosome-inactivating proteins (RIPs) on the rat retina. Br Neurosci Assoc Abstr 2005;18:393.
18. Taskintuna I, Banker AS, Rao NA, Wiley CA, Flores-Aguilar M, Munguia D, Bergeron-Lynn G, De Clercq E, Keefe K, Freeman WR: An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects. Exp Eye Res 1997;64:795-806.
19. Cheng L, Hostetler KY, Chaidhawangul S, Gardner MF, Beadle JR, Keefe KS, Bergeron-Lynn G, Severson GM, Soules KA, Mueller AJ, Freeman WR: Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation. Invest Ophthalmol Vis Sci 2000;41:1523-1532.
20. Bui BV, Fortune B: Ganglion cell contributions to the rat full-field electroretinogram. J Physiol 2004;555:153-173.
21. Gao H, Pennesi ME, Shah K, Qiao X, Hariprasad SM, Mieler WF, Wu SM, Holz ER: Intravitreal voriconazole: an electroretinographic and histopathologic study. Arch Ophthalmol 2004;122:1687-1692.
22. Swanson KI, Schlieve CR, Lieven CJ, Levin LA: Neuroprotective effect of sulfhydryl reduction in a rat optic nerve crush model. Invest Ophthalmol Vis Sci 2005;46:3737-3741.
23. Mauger TF, Nye CN, Boyle KA: Intraocular pressure, anterior chamber depth and axial length following intravenous mannitol. J Ocul Pharmacol Ther 2000;16:591-594.
24. Smith ME, Kincaid MC, West CE: Basic Science, Refraction, and Pathology. St. Louis, Mosby, 2002.
25. Koretz JF, Cook CA, Kaufman PL: Aging of the human lens: changes in lens shape at zero-diopter accommodation. J Opt Soc Am A Opt Image Sci Vis 2001;18:265-272.
26. Chee KS, Kistler J, Donaldson PJ: Roles for KCC transporters in the maintenance of lens transparency. Invest Ophthalmol Vis Sci 2006;47:673-682.
27. Zintz C, Beebe DC: Morphological and cell volume changes in the rat lens during the formation of radiation cataracts. Exp Eye Res 1986:42:43-54.
28. Merriman-Smith BR, Young MA, Jacobs MD, Kistler J, Donaldson PJ: Molecular identification of P-glycoprotein: a role in lens circulation? Invest Ophthalmol Vis Sci 2002;43:3008-3015.
29. Jacob TJ: The relationship between cataract, cell swelling and volume regulation. Prog Retin Eye Res 1999;18:223-233.
30. Shui YB, Kojima M, Sasaki K: A new steroidinduced cataract model in the rat: long-term prednisolone applications with a minimum of X-irradiation. Ophthalmic Res 1996;28 (suppl 2):92-101.
31. Rodriguez-Sargent C, Berrios G, Irrizarry JE, Estape ES, Cangiano JL, Martinez-Maldonado M: Prevention and reversal of cataracts in genetically hypertensive rats through sodium restriction. Invest Ophthalmol Vis Sci 1989;30:2356-2360.
32. Burns MS, File DM: Quantitative microlocalization of diffusible ions in normal and galactose cataractous rat lens by secondary ion mass spectrometry. J Microsc 1986;144:157-182.
33. Patterson JW: The effect of ouabain on volume regulation in the rat lens. Invest Ophthalmol Vis Sci 1981;20:40-46.
34. Manabe S, Lipton SA: Divergent NMDA signals leading to proapoptotic and antiapoptotic pathways in the rat retina. Invest Ophthalmol Vis Sci 2003;44:385-392.
35. Klöcker N, Kermer P, Weishaupt JH, Labes M, Ankerhold R, Bähr M: Brain-derived neurotrophic factor-mediated neuroprotection of adult rat retinal ganglion cells in vivo does not exclusively depend on phosphatidyl-inositol-3′-kinase/protein kinase B signaling. J Neurosci 2000;20:6962-6967.
36. Cheng L, Sapieha P, Kittlerová P, Hauswirth WW, Polo AD: TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo. J Neurosci 2002;22:3977-3986.
37. Ciulla TA, Criswell MH, Danis RP, Fronheiser M, Yuan P, Cox TA, Csaky KG, Robinson MR: Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants. Br J Ophthalmol 2003;87:1032-1037.
38. Lu M, Amano S, Miyamoto K, Garland R, Keough K, Qin W, Adamis AP: Insulin-induced vascular endothelial growth factor expression in retina. Invest Ophthalmol Vis Sci 1999;40:3281-3286.
39. Berkowitz BA, Lukaszew RA, Mullins CM, Penn JS: Impaired hyaloidal circulation function and uncoordinated ocular growth patterns in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci 1998;39:391-396.
40. Penn JS, Rajaratnam VS: Inhibition of retinal neovascularization by intravitreal injection of human rPAI-1 in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 2003;44:5423-5429.
41. Zhang W, Ito Y, Berlin E, Roberts R, Berkowitz BA: Role of hypoxia during normal retinal vessel development and in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci 2003;44:3119-3123.
42. Laurie NA, Gray JK, Zhang J, Leggas M, Relling M, Egorin M, Stewart C, Dyer MA: Topotecan combination chemotherapy in two new rodent models of retinoblastoma. Clin Cancer Res 2005;11:7569-7578.
43. Tamas A, Gabriel R, Racz B, Denes V, Kiss P, Lubics A, Lengvari I, Reglodi D: Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodium-glutamate. Neurosci Lett 2004;372:110-113.
44. Beauchamp MH, Marrache AM, Hou X, Gobeil F Jr, Bernier SG, Lachapelle P, Abran D, Quiniou C, Brault S, Peri KG, Roberts J 2nd, Almazan G, Varma DR, Chemtob S: Platelet-activating factor in vasoobliteration of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 2002;43:3327-3337.
45. Gilger BC, Reeves KA, Salmon JH: Ocular parameters related to drug delivery in the canine and equine eye: aqueous and vitreous humor volume and scleral surface area and thickness. Vet Ophthalmol 2005;8:265-269.
46. Wilson CA, Berkowitz BA, McCuen BW 2nd, Charles HC: Measurement of preretinal oxygen tension in the vitrectomized human eye using fluorine-19 magnetic resonance spectroscopy. Arch Ophthalmol 1992;110:1098-1100.
47. O'Brien JM, Char DH, Tucker N, Gordon KB, Norman D: Efficacy of unanesthetized spiral computed tomography scanning in initial evaluation of childhood leukocoria. Ophthalmology 1995;102:1345-1350.
48. Asano H: Measurement of the subretinal fluid volume using B-scan ultrasonography. Report 2. Measurement of the decrease rate of subretinal fluid in patients with rhegmatogenous retinal detachment. Nippon Ganka Gakkai Zasshi 1993;97:532-537.
49. Dorph-Petersen KA, Nyengaard JR, Gundersen HJ: Tissue shrinkage and unbiased stereological estimation of particle number and size. J Microsc 2001;204:232-246.
50. Gardella D, Hatton WJ, Rind HB, Rosen GD, von Bartheld CS: Differential tissue shrinkage and compression in the z-axis: implications for optical disector counting in vibratome-, plastic- and cryosections. J Neurosci Methods 2003;124:45-59.
51. Berkowitz BA, Lukaszew RA, Mullins CM, JS Penn: Impaired hyaloidal circulation function and uncoordinated ocular growth patterns in experimental retinopathy of prematurity. Invest Ophthalmol Vis Sci 1998;39:391-396.
52. Berkowitz BA, Roberts R, Luan H, Peysakhov J, Mao X, Thomas KA: Dynamic contrast-enhanced MRI measurements of passive permeability through blood retinal barrier in diabetic rats. Invest Ophthalmol Vis Sci 2004;45:2391-2398.